Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s …

CouponFollow Extension

$4
OFF

Moderna (MRNA) Beats On Q4 Earnings & Sales, Reiterates View

2 weeks from now

Feb 22, 2024 · Moderna (MRNA) beats expectations for earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.

yahoo.com

6%
OFF

Here's What To Expect From Moderna's Next Earnings Report

2 weeks from now

Jan 28, 2025 · The company is set to announce its Q4 earnings on Thursday, Feb. 27. Ahead of the event, analysts expect Moderna to report a loss of $2.94 per share , down 634.6% from …

nasdaq.com

$0.55
OFF

Moderna (MRNA) Q4 Earnings And Revenues Beat Estimates

2 weeks from now

Feb 22, 2024 · Moderna (MRNA) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of a loss of $0.78 per share. This compares to earnings of $3.61 …

nasdaq.com

$0.98
OFF

Here's What Wall Street Expects From Moderna's Earnings Report

2 weeks from now

Feb 21, 2024 · Moderna releases earnings for the most recent quarter on February 22. 18 analysts are predicting losses of $0.987 per share compared to earnings of $3.61 per share in …

businessinsider.com

8%
OFF

Moderna (MRNA) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

3 days ago · Moderna posted Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.03, which beat the consensus estimate of -$1.89 by $1.92. Quarterly revenue rose 3.8% …

marketbeat.com

3%
OFF

Are These 5 Biotech Stocks Set To Beat Q4 Earnings Estimates?

2 weeks from now

The Earnings Trends report indicates that as of Jan. 29, 12.3% of the companies in the Medical sector — representing 30.8% of the sector’s market capitalization — reported quarterly …

yahoo.com

$128
OFF

Monolithic Power Q4 Earnings Beat Estimate On Solid Revenue …

2 weeks from now

8 hours ago · In the fourth quarter, the Automotive segment contributed $128.4 million in revenues compared with $89.8 million in the year-ago quarter. The figure beat Zacks Consensus …

nasdaq.com

1%
OFF

Kenvue (KVUE) Q4 Earnings: Taking A Look At Key Metrics Versus …

2 weeks from now

For the quarter ended December 2024, Kenvue (KVUE) reported revenue of $3.66 billion, down 0.1% over the same period last year. EPS came in at $0.26, compared to $0.31 in the year …

yahoo.com

FAQs about Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards? Coupon?

Will Moderna (mRNA) beat expectations for Q4 earnings?

Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates? We expect Moderna MRNA to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 22, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 30.85%. ...

How did Moderna (mRNA) perform in Q4 2023?

Moderna, Inc. MRNA reported earnings of 55 cents per share in the fourth quarter of 2023, beating the Zacks Consensus Estimate of a loss of 78 cents. Earnings declined 85% in the quarter. The year-over-year decline in the bottom line was due to lower product sales during the quarter. ...

How much money does Moderna make a year?

Moderna (NASDAQ:MRNA) has a recorded annual revenue of $5.06 billion. How much profit does Moderna generate each year? Moderna (NASDAQ:MRNA) has a recorded net income of -$4.71 billion. MRNA has generated -$5.82 earnings per share over the last four quarters. ...

Why were Moderna's shares up 61% in pre-market trading?

Moderna’s shares were up 6.1% in pre-market trading on Feb 22, likely due to the better-than-expected earnings reported by the company. Investors were expecting the company to report a loss in the fourth quarter. However, the company’s positive earnings in the quarter took the investor community by surprise. ...

How much money did Moderna make in 2024?

2024 financial updates: Moderna achieved 2024 product sales in the range of approximately $3.0 to 3.1 billion (unaudited), comprising $1.7 billion in the U.S. and $1.3 to 1.4 billion in Rest of World. This includes more than $3.0 billion in Spikevax® sales and minimal sales from mRESVIA®. ...

Is Moderna a good stock to buy or sell?

You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Moderna has an Earnings ESP of 3.26% and a Zacks Rank #3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. ...